Win Advisors’s Abbott ABT Stock Holding History

Win Advisors’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-156	Closed	-$17.1K	–	38
2022 Q4	$17.1K	Buy	+156	New	+$16.2K	0.01%	96

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Win Advisors's ABT Position: Q1 2023 in Review

Win Advisors sold out of Abbott (ABT) in Q1 2023, closing a stake of 156 shares — an estimated $17.1K sold.

Win Advisors first reported a position in ABT in Q4 2022 and held it in 1 quarter. The position peaked at $17.1K in Q4 2022. 2,704 funds tracked by Wall St. Rank hold ABT as of Q1 2023.

Win Advisors reported no remaining Abbott position as of Q1 2023 after selling out during the quarter.
Win Advisors sold 156 Abbott shares in Q1 2023, an estimated $17.1K.
Win Advisors first reported a position in Abbott in Q4 2022 and held it in 1 quarter.
Win Advisors's Abbott position peaked at $17.1K in Q4 2022.
2,704 funds tracked by Wall St. Rank held Abbott as of Q1 2023.

Based on Win Advisors's 13F filing for Q1 2023, filed 28 Apr 2023.